Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-06-06
1999-01-05
Ulm, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530350, C07K 14705
Patent
active
058562966
ABSTRACT:
Mammalian Interleukin-4 receptor proteins, DNAs and expression vectors encoding mammalian IL-4 receptors, and processes for producing mammalian IL-4 receptors as products of cell culture, are disclosed. A method for suppressing an IL-4-dependent immune or inflammatory response in a mammal, including a human, by administering an effective amount of soluble IL-4 receptor (sIL-4R) and a suitable diluent or carrier.
REFERENCES:
patent: 4551433 (1985-11-01), DeBoer
patent: 4675285 (1987-06-01), Clark et al.
patent: 4683199 (1987-07-01), Palladino
patent: 5449756 (1995-09-01), Taniguchi et al.
Ohara and Paul, "Receptors for B-cell stimulatory factor-1 expressed on cells of haematopoietic lineage", Nature 325:537-540, 1987.
Park et al., "Characterization of the high-affinity cell-surface receptor for murine B-cell-stimulating factor 1", Proc. Nat. Acad. Sci. USA, 84:1669-1673, 1987.
Park et al., "Characterization of the Human B Cell Stimulatory Factor 1 Receptor", J. Exp. Med., 166:476-488, 1987.
Nakajima et al., "Detection of Receptors for Murine B Cell Stimulatory Factor 1 (BSF1): Presence of Functional Receptors on CBA/N Splenic B Cells", J. Immunol. 139:774-779, 1987.
Cabrillat et al., "High Affinity Binding of Human Interleukin 4 to Cell Lines", Biochem. & Biophys. Res. Commun. 149:995-1001, 1987.
Lowenthal et al., "Expression of High Affinity Receptors for Murine Interleukin 4 (BSF1)", J. Immunol. 140:456-464, 1988.
Lowenthal et al., "Up-Regulation of Interleukin 4 Receptor Expression on Immature (Lyt-2.sup.- /L3T4.sup.-) Thymocytes", J. Immunol. 140:474-478, 1988.
Park et al., "Interleukin-4 Binds to Murine Fibroblasts: Receptor Characterization and Induction of Colony Stimulating Activity Production", UCLA Symposia Abstracts, J. Cell Biochem. Suppl. 12A, 1988.
Dower et al., "Interleukin Receptors", ISI Atlas of Science: Immunology, 116-120, 1988.
Okayama and Berg, "High-Efficiency Cloning of Full-Length cDNA", Mol. Cell. Biol. 2:161-170, 1983.
Okayama and Berg, "A cDNA Cloning Vector that Permits Expression of cDNA Inserts in Mammalian Cells", Mol. Cell. Biol. 3:280-289, 1983.
Aruffo and Seed, "Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system", Proc. Natl. Acad. Sci. USA 84:8573-8577, 1987.
Yamasaki et al., "Cloning and Expression of the Human Interleukin-6 (BSF-2/IFN.beta.2) Receptor", Science 241:825-828, 1988.
Sims et al., "cDNA Expression Cloning of the IL-1 Receptor, a Member of the Immunoglobulin Superfamily", Science 241:585-589, 1988.
De Maagd et al., "The human thymus microenvironment: heterogeneity detected by monoclonal anti-epithelial cell antibodies", Immunology 54:745-754, 1985.
Larche et al., "A novel T-lymphocyte molecue that may function in the induction of self-tolerance and MHC-restriction within the human thymic microenvironment", Immunology 64:101-105, 1988.
Larche et al., "Functional evidence for a monoclonal antibody that binds to the human IL-4 receptor", Immunology 65:617-622, 1988.
Jabaari et al., British J. Cancer 59 (6) 910-914, 1989.
Salari et al., Biochem. J. 262:897-908, 1989.
Urdal et al., "Studies on Hematopoietic Growth Factor Receptors Using Human Recombinant IL-3, GM-CSF, G-CSF, M-CSF, IL-1 and IL-4", Behring Inst. Mitt. 83:27-39, Aug., 1988.
Harada et al., "Expression cloning of a cDNA encoding the murine interleukin 4 receptor based on ligand binding", Proc. Natl. Acad. Sci. USA 87:857-861, 1990.
Mosley et al., "The Murine Interleukin-4 Receptor: Molecular Cloning and Characterization of Secreted and Membrane Bound Forms", Cell 59:335-348, Oct., 1989.
Finkelman et al., "Il-4 Is Required to Generate and Sustain In Vivo IgE Responses", J. Immunol. 141:2335-2341, 1988.
Finkelman et al., "Suppression of in vivo polyclonal IgE responses by monoclonal antibody to the lymphokine B-cell stimulatory factor 1", Proc. Natl. Acad. Sci. USA 83:9675-9678, 1986.
Snapper et al., "Differential Regulation of IgG1 and IgE Synthesis by Interleukin 4", J. Exp. Med. 167:183-196, 1988.
Finkelman et al., "T Help Requirements for the Generation of an In Vivo IgE Response: A Late Acting Form of T Cell Help Other Than IL-4 Is Required for IgE but not for IgG1 Production", J. Immunol. 142:403-408, 1989.
Galizzi et al., "Purification of a 130-kDa T Cell Glycoprotein That Binds Human Interleukin 4 with High Affinity", J. Biol. Chem. 265:439-444, 1990.
Galizzi et al., "Internalization of Human Interleukin 4 and Transient Down-regulation of Its Receptor in the C23-inducible Jijoye Cells", J. Biol. Chem. 264:6984-6989, 1989.
Chester and Hawkins, "Clinical issues in antibody design", Tibtech 13:294-300, 1995.
Paul, William E., Ed., Fundamental Immunology, Raven Press, New York, 1993, p. 826.
Beckmann M. Patricia
Cosman David J.
Idzerda Rejean
March Carl J.
Mosley Bruce
Anderson Kathryn A.
Immunex Corporation
Ulm John
Wight Christopher L.
LandOfFree
DNA encoding interleukin-4 receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DNA encoding interleukin-4 receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA encoding interleukin-4 receptors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-862320